Vericel (VCEL) Other Non-Current Assets (2019 - 2026)

Vericel's (VCEL) quarterly Other Non-Current Assets came in at $288000.0 in Q1 2026, down 42.51% year-on-year from $501000.0 in Q1 2025, and down 15.54% quarter-over-quarter from $341000.0 in Q4 2025.

Vericel (VCEL) Other Non-Current Assets (2019 - 2026) Analysis & Trends

Vericel has disclosed Other Non-Current Assets across 8 years of filings, most recently posting $288000.0 for Q1 2026.

  • Other Non-Current Assets for Q1 2026 came in at $288000.0, down 42.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $288000.0 (down 42.51% YoY), and the FY2025 annual result was $341000.0, down 38.67% from the prior year.
  • Other Non-Current Assets came in at $288000.0 for Q1 2026 at Vericel, down from $341000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $43.0 million in Q2 2023 to a low of $288000.0 in Q1 2026.
  • The 5-year median for Other Non-Current Assets is $717000.0 (2024), against an average of $3.9 million.
  • Across the five-year window, Other Non-Current Assets jumped 2830.81% in 2022 and tumbled 98.46% in 2024, its largest moves.
  • Vericel's Other Non-Current Assets stood at $1.3 million in 2022, then plunged by 40.83% to $771000.0 in 2023, then decreased by 27.89% to $556000.0 in 2024, then slumped by 38.67% to $341000.0 in 2025, then decreased by 15.54% to $288000.0 in 2026.
  • The last three Other Non-Current Assets figures came in at $288000.0 (Q1 2026), $341000.0 (Q4 2025), and $395000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 12.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 60,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Vericel 2.04 Bn 1.90 Bn 49.27 Mn 288,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 288,000.00
Dec 31, 2025 341,000.00
Sep 30, 2025 395,000.00
Jun 30, 2025 447,000.00
Mar 31, 2025 501,000.00
Dec 31, 2024 556,000.00
Sep 30, 2024 610,000.00
Jun 30, 2024 664,000.00
Mar 31, 2024 717,000.00
Dec 31, 2023 771,000.00
Sep 30, 2023 1.14 Mn
Jun 30, 2023 43.00 Mn
Mar 31, 2023 1.25 Mn
Dec 31, 2022 1.30 Mn
Sep 30, 2022 1.36 Mn
Jun 30, 2022 6.18 Mn
Mar 31, 2022 6.18 Mn
Dec 31, 2021 211,000.00
Sep 30, 2021 211,000.00
Jun 30, 2021 211,000.00